AnalytiCon Discovery

Potsdam, Germany Founded: 2000 • Age: 26 yrs Acquired By BRAIN
Natural products chemistry is specialized in by AnalytiCon Discovery.

About AnalytiCon Discovery

AnalytiCon Discovery is a company based in Potsdam (Germany) founded in 2000 was acquired by BRAIN in July 2014.. AnalytiCon Discovery has raised $3.04 million across 4 funding rounds from investors including Brain Biotech, European Union and Berlin Capital Fund. AnalytiCon Discovery offers products and services including Screening Libraries and Discovery Services. AnalytiCon Discovery operates in a competitive market with competitors including C2 Pharma, Magellan BioScience Group, Metagreen, BJ Biochem and Alluvium Biosciences, among others.

  • Headquarter Potsdam, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Brain Biotech Ag
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.04 M (USD)

    in 4 rounds

  • Latest Funding Round
    $580.54 K (USD), Grant

    Jun 01, 2021

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    BRAIN

    (Jul 03, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AnalytiCon Discovery

AnalytiCon Discovery offers a comprehensive portfolio of products and services, including Screening Libraries and Discovery Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Offers libraries for natural product screening in drug discovery

Provides development and discovery for pharmaceuticals and cosmetics

People of AnalytiCon Discovery
Headcount 50-200
Employee Profiles 2
Employee Profiles
People
Dietmar Wolf
Chief Business Officer
People
Lars Ole Haustedt
VP Projects & Innovation

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of AnalytiCon Discovery

AnalytiCon Discovery has successfully raised a total of $3.04M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $580.54 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $580,543
  • First Round

    (28 Apr 2005)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2021 Amount Grant - AnalytiCon Discovery Valuation

investors

Jan, 2018 Amount Grant - AnalytiCon Discovery Valuation

investors

May, 2015 Amount Grant - AnalytiCon Discovery Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AnalytiCon Discovery

AnalytiCon Discovery has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Brain Biotech, European Union and Berlin Capital Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Investments are directed by Brandenburg Capital toward multiple sectors.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AnalytiCon Discovery

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AnalytiCon Discovery

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Analyticon Discovery Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AnalytiCon Discovery

AnalytiCon Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as C2 Pharma, Magellan BioScience Group, Metagreen, BJ Biochem and Alluvium Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
domain founded_year HQ Location
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
domain founded_year HQ Location
Develops technologies to harness compounds from natural production.
domain founded_year HQ Location
Research and development services for sugar derivatives are provided.
domain founded_year HQ Location
Specializes as a preclinical CRO, developing high-value small molecules derived from natural sources for clients.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Analyticon Discovery

Frequently Asked Questions about AnalytiCon Discovery

When was AnalytiCon Discovery founded?

AnalytiCon Discovery was founded in 2000 and raised its 1st funding round 5 years after it was founded.

Where is AnalytiCon Discovery located?

AnalytiCon Discovery is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.

Is AnalytiCon Discovery a funded company?

AnalytiCon Discovery is a funded company, having raised a total of $3.04M across 4 funding rounds to date. The company's 1st funding round was a Grant of $597.55K, raised on Apr 28, 2005.

What does AnalytiCon Discovery do?

AnalytiCon Discovery was established in 2000 and is headquartered in Potsdam, Germany. Focus is placed on natural products chemistry within the chemical research sector. Services encompass discovery, isolation, and structural elucidation of compounds from natural sources. Operations are conducted through laboratory-based analysis and collaboration on pharmaceutical and biotech projects. The domain ac-discovery.com serves as the primary online presence for these activities.

Who are the top competitors of AnalytiCon Discovery?

AnalytiCon Discovery's top competitors include BJ Biochem, Magellan BioScience Group and Synaco Group.

What products or services does AnalytiCon Discovery offer?

AnalytiCon Discovery offers Screening Libraries and Discovery Services.

Who are AnalytiCon Discovery's investors?

AnalytiCon Discovery has 4 investors. Key investors include Brain Biotech, European Union, Berlin Capital Fund, and Brandenburg Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available